Core Viewpoint - The company is expected to report a net profit loss of between 53 million to 66 million yuan for the year 2025 due to declining revenue and competitive pressures in the magnetic resonance imaging (MRI) equipment market [1] Group 1: Financial Performance - For the first three quarters of 2025, the company's main revenue was 67.74 million yuan, a year-on-year decrease of 21.33% [1] - The net profit attributable to the parent company for the same period was -19.33 million yuan, down 21.77% year-on-year [1] - The company's third-quarter revenue was 20.39 million yuan, reflecting a year-on-year decline of 29.57% [1] Group 2: Market Conditions - The MRI system market in China remains highly competitive, particularly with leading companies adopting bulk purchasing policies that significantly lower bidding prices [1] - The sales revenue of the company's 1.5T MRI systems has been adversely affected by this competitive landscape [1] - The 7.0T MRI system, being a niche research product with high pricing, has not achieved sales in 2025, further impacting overall revenue [1] Group 3: Financial Metrics - The company's debt ratio stands at 48.48% [1] - Investment income reported was 239,000 yuan, while financial expenses amounted to 3.85 million yuan [1] - The gross profit margin for the company is 49.73% [1]
辰光医疗：预计2025年全年归属净利润亏损5300万元至6600万元